Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2013, Article ID 427141, 5 pages
http://dx.doi.org/10.1155/2013/427141
Case Report

An Unexpected Complete Remission of Advanced Intestinal-Type Vulvar Adenocarcinoma after Neoadjuvant Chemotherapy: A Case Report and a Literature Review

1Department of Gynecology, Obstetrics and Urological Sciences, Sapienza University of Rome, Viale del Policlinico, 155-00161 Rome, Italy
2Department of Experimental Medicine and Pathology, Sapienza University of Rome, Viale Regina Elena, 324-00161 Rome, Italy

Received 11 August 2013; Accepted 25 September 2013

Academic Editors: M. Hanssens and R. Shaco-Levy

Copyright © 2013 Angela Musella et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. L. Judson, E. B. Habermann, N. N. Baxter, S. B. Durham, and B. A. Virnig, “Trends in the incidence of invasive and in situ vulvar carcinoma,” Obstetrics and Gynecology, vol. 107, no. 5, pp. 1018–1022, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. S. A. Ghamande, J. Kasznica, C. Thomas Griffiths, N. J. Finkler, and A. M. Hamid, “Mucinous adenocarcinomas of the vulva,” Gynecologic Oncology, vol. 57, no. 1, pp. 117–120, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. J. C. Kennedy and B. Majmudar, “Primary adenocarcinoma of the vulva, possibly cloacogenic: a report of two cases,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 38, no. 2, pp. 113–116, 1993. View at Google Scholar · View at Scopus
  4. S. Nasir, H. Zaidi, and M. G. Conner, “Primary vulvar adenocarcinoma of cloacogenic origin,” Southern Medical Journal, vol. 94, no. 7, pp. 744–746, 2001. View at Google Scholar · View at Scopus
  5. A. J. Tiltman and V. K. Knutzen, “Primary adenocarcinoma of the vulva originating in misplaced cloacal tissue,” Obstetrics and Gynecology, vol. 51, no. 1, 1978. View at Google Scholar · View at Scopus
  6. R. Willen, Z. Be kassy, B. Carlen, B. Bozoky, and S. Cajander, “Cloacogenic adenocarcinoma of the vulva,” Gynecologic Oncology, vol. 74, p. 298, 1999. View at Google Scholar
  7. A. Rodriguez, M. A. Isaac, E. Hidalgo, B. Márquez, and F. F. Nogales, “Villoglandular adenocarcinoma of the vulva,” Gynecologic Oncology, vol. 83, no. 2, pp. 409–411, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Dubé, C. Veilleux, M. Plante, and B. Têtu, “Primary villoglandular adenocarcinoma of cloacogenic origin of the vulva,” Human Pathology, vol. 35, no. 3, pp. 377–379, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. S.-H. Liu, C.-M. Ho, S.-H. Huang, B.-Y. Shih, and F.-K. Lee, “Cloacogenic adenocarcinoma of the vulva presenting as recurrent Bartholin's gland infection,” Journal of the Formosan Medical Association, vol. 102, no. 1, pp. 49–51, 2003. View at Google Scholar · View at Scopus
  10. G. Cormio, C. Carriero, V. Loizzi et al., “‘Intestinal-type’ mucinous adenocarcinoma of the vulva: a report of two cases,” European Journal of Gynaecological Oncology, vol. 33, no. 4, pp. 433–435, 2012. View at Google Scholar
  11. R. Karkouche, F. Ansart, B. Terris, M. C. Lavenu, and F. Plantier, “Multiple tubulovillous adenomas of the vulva,” American Journal of Dermatopathology, vol. 34, no. 3, pp. 321–324, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. T. S. Loy, R. D. Calaluce, and G. L. Keeney, “Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma,” Modern Pathology, vol. 9, no. 11, pp. 1040–1044, 1996. View at Google Scholar · View at Scopus
  13. W. G. McCluggage, R. Shah, L. E. Connolly, and H. A. McBride, “Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2,” International Journal of Gynecological Pathology, vol. 27, no. 1, pp. 92–100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. de Hullu, I. A. M. van der Avoort, M. H. M. Oonk, and A. G. J. van der Zee, “Management of vulvar cancers,” European Journal of Surgical Oncology, vol. 32, no. 8, pp. 825–831, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. F. B. Stehman, B. N. Bundy, P. M. Dvoretsky, and W. T. Creasman, “Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group,” Obstetrics and Gynecology, vol. 79, no. 4, pp. 490–497, 1992. View at Google Scholar · View at Scopus
  16. M. Raitanen, V. Rantanen, J. Kulmala, H. Helenius, R. Grénman, and S. Grénman, “Supra-additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro,” International Journal of Cancer, vol. 100, no. 2, pp. 238–243, 2002. View at Publisher · View at Google Scholar · View at Scopus